LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in OGN — Organon & Co.
CIK 932974
BOSTON, MA
Position in OGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,628
-$523 QoQ
Shares Held
268
-61.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#381
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $220,949,345 across 14 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
59,780 | $71,701,930 | |
| 2 | JNJ |
Johnson & Johnson
|
252,775 | $64,197,266 | |
| 3 | MRK |
Merck & Co., Inc.
|
332,735 | $42,756,447 | |
| 4 | AMGN |
Amgen Inc
|
50,038 | $18,119,760 | |
| 5 | ABBV |
AbbVie Inc.
|
61,527 | $15,482,654 | |
| 6 | NVS |
Novartis AG
|
11,917 | $1,867,632 | |
| 7 | NVO |
Novo Nordisk A S
|
36,192 | $1,735,044 | |
| 8 | PFE |
Pfizer Inc
|
56,816 | $1,368,129 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,628 | 268 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,151 | 693 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $4,968 | 693 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $12,837 | 1,202 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $13,803 | 1,426 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $21,248 | 1,427 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $21,290 | 1,427 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $27,317 | 1,428 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $36,432 | 1,760 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $32,862 | 1,748 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $28,825 | 1,999 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $44,059 | 2,538 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $52,815 | 2,538 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $66,044 | 2,808 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $81,918 | 2,933 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $70,948 | 3,032 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $118,530 | 3,512 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $176,326 | 5,048 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $173,686 | 5,704 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $261,205 | 7,966 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $552,819 | 18,269 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||